Novartis touts Arzerra's CLL study results; Teva taps former Israeli president as consultant; Richter med gets EU backing;

@FiercePharma: Figo launches new pet insurance plans amid booming market. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: Lilly's Elanco unloading Novartis California vax plant it picked up in animal health deal. FiercePharmaManufacturing report | Follow @EricPFierce

@CarlyHFierce: Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva. Release | Follow @CarlyHFierce

> Novartis ($NVS) said its blood cancer drug Arzerra hit its goal in a Phase III study in relapsed patients with chronic lymphocytic leukemia (CLL). Release

> Former Israeli President Shimon Peres has signed on as a consultant at Teva Pharmaceutical ($TEVA), planning to donate his $10,000-per-month pay to charity. Report

> A gynecological drug from Hungary-based Richter, Esmya, won a European recommendation for long-term use against uterine fibroid symptoms. Report

> The U.S. Supreme Court is set to hear arguments over a drug the state of Oklahoma used in executions after the usual injections ran scarce. Report

> Brazilian drugmaker Hypermarcas posted flat profits for the first quarter, as higher sales were offset by higher costs. Report

> Moberg Pharma bought Balmex brand over-the-counter products in the U.S. for $3.9 million. Report

Medical Device News

@FierceMedDev: ICYMI from FierceDiagnostics: Veracyte unveils $40M private placement to generate cash for R&D. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Updated w/ $MDT comment: Medtronic facing new wrongful death lawsuit over failed insulin pump in wake of 2009 recall. More | Follow @VarunSaxena2

@EmilyWFierce: Neuronetics raised $34.3M in a Series F round led by $GE for noninvasive magnetic stimulation device for depression. More from the WSJ | Follow @EmilyWFierce

> Sorin Group touts study showing its flexible implant for mitral valve disease is better than Medtronic's. More

> Spectranetics shares slump as the medical laser maker snips forecast. Story

> Boston Scientific loses bid to throw out claims tied to vaginal mesh device. Report

Biotech News

@FierceBiotech: Biogen partner Sobi and its Boston-based CEO field a takeover bid. News | Follow @FierceBiotech

@JohnCFierce: No, $BLUE is not $CLDN. Not hard to separate these companies' technology/pipelines. | Follow @JohnCFierce

@DamianFierce: tal im' oh jeen la her" pa rep' vek. Amgen file | Follow @DamianFierce

> FDA review challenges Amgen on a questionable T-Vec study. Story

> Synta CEO bolts after less than a year, leaving a biotech on the mend. News

> Celgene bags a build-to-buy biotech in $485M cancer deal. Report

Animal Health News

> Bayer closes MO animal health plant, citing excess capacity. News

> New study warns you can catch diseases from your pets. Story

> Lilly beats estimates on newly bulked-up animal health unit. Item

> Fallout continues in wake of avian bird flu spreading across the U.S. More

> Dog data at AACR cancer confab may point to personalized treatments. Report

Biotech IT News

> Quest, LabCorp team to build database of cancer genetics. News

> Edico and Intel set sights on real-time whole genome analysis. More

> Lilly, Novartis and Pfizer give trial-patient matching tech to TrialReach. Report

> WuXi invests $15M in DNAnexus to fuel push into China. Story

> AstraZeneca tightens ties to Roche's informatics platform provider. Article

And Finally... U.S. scientists are scrambling to gain understanding of newly emergent avian flu viruses. Report